Lifco（1LIFC）株式概要Lifco AB（publish）は、スウェーデン、ノルウェー、ドイツ、その他のヨーロッパ、英国、アジア、オーストラリア、イタリア、北米、および国際的な歯科、解体・工具、システムソリューション事業に従事している。 詳細1LIFC ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長2/6過去の実績3/6財務の健全性5/6配当金4/6報酬当社が推定した公正価値より8.3%で取引されている 収益は年間9.36%増加すると予測されています 過去5年間の収益は年間11.3%増加しました。 リスク分析Italian市場と比較した過去 3 か月間の株価の変動すべてのリスクチェックを見る1LIFC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€28.746.7% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture038b2016201920222025202620282031Revenue SEK 38.4bEarnings SEK 5.0bAdvancedSet Fair ValueView all narrativesLifco AB (publ) 競合他社ItalmobiliareSymbol: BIT:ITMMarket cap: €1.2bLeonardoSymbol: BIT:LDOMarket cap: €28.9bDanieli & C. Officine MeccanicheSymbol: BIT:DANMarket cap: €4.6bFincantieriSymbol: BIT:FCTMarket cap: €3.9b価格と性能株価の高値、安値、推移の概要Lifco過去の株価現在の株価SEK 28.7452週高値SEK 35.7052週安値SEK 26.00ベータ1.161ヶ月の変化12.27%3ヶ月変化7.96%1年変化-18.17%3年間の変化n/a5年間の変化n/aIPOからの変化-15.47%最新ニュースBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Anders Oscarsson was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 25Lifco AB (Publ) Appoints Anders Oscarsson as New Member of the BoardLifco AB (publ) at its AGM held on 24 April 2026 approved that Anders Oscarsson was elected new member of the Board.お知らせ • Mar 17Lifco AB (publ) to Report Fiscal Year 2026 Final Results on Mar 30, 2027Lifco AB (publ) announced that they will report fiscal year 2026 final results on Mar 30, 2027お知らせ • Mar 11Lifco AB (publ) to Report Fiscal Year 2025 Final Results on Mar 30, 2026Lifco AB (publ) announced that they will report fiscal year 2025 final results on Mar 30, 2026Valuation Update With 7 Day Price Move • Mar 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €27.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 14x in the Industrials industry in Europe. Total loss to shareholders of 20% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €26.67 per share.お知らせ • Jan 31+ 1 more updateLifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd on January 30, 2026. As part of the transaction, Ethoss will be consolidated in Business Area Dental. For the period ending July 31, 2025, Ethoss Regeneration Ltd reported total revenue of approximately £5.4 million. The expected completion of the transaction is in the first quarter of 2026.最新情報をもっと見るRecent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Anders Oscarsson was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 25Lifco AB (Publ) Appoints Anders Oscarsson as New Member of the BoardLifco AB (publ) at its AGM held on 24 April 2026 approved that Anders Oscarsson was elected new member of the Board.お知らせ • Mar 17Lifco AB (publ) to Report Fiscal Year 2026 Final Results on Mar 30, 2027Lifco AB (publ) announced that they will report fiscal year 2026 final results on Mar 30, 2027お知らせ • Mar 11Lifco AB (publ) to Report Fiscal Year 2025 Final Results on Mar 30, 2026Lifco AB (publ) announced that they will report fiscal year 2025 final results on Mar 30, 2026Valuation Update With 7 Day Price Move • Mar 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €27.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 14x in the Industrials industry in Europe. Total loss to shareholders of 20% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €26.67 per share.お知らせ • Jan 31+ 1 more updateLifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd on January 30, 2026. As part of the transaction, Ethoss will be consolidated in Business Area Dental. For the period ending July 31, 2025, Ethoss Regeneration Ltd reported total revenue of approximately £5.4 million. The expected completion of the transaction is in the first quarter of 2026.お知らせ • Jan 30Lifco AB (publ) Proposes Dividend for the Year 2025, Payable on 6 May 2026The Board of Directors of Lifco AB (publ) and Chief Executive Officer proposed that the Annual General Meeting authorise the payment of a dividend of SEK 2.70 per share (SEK 2.40 per share) for 2025, representing a total distribution of SEK 1,226.4 million (SEK 1,090.1 million). This is equal to 33.8% (33.0%) of the net profit for the year attributable to shareholders of Lifco AB. The proposed record date for the dividend is 30 April 2026. Euroclear Sweden expects to be able to distribute the dividend to the shareholders on 6 May 2026, subject to the resolution of the Annual General Meeting.お知らせ • Nov 26Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Db Orthodontics Limited.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Db Orthodontics Limited on November 25, 2025. DB Orthodontics Limited will be consolidated in Business Area Dental. In the financial year ended October 2025, DB Orthodontics Limited reported net sales of approximately £8.9 million. The transaction is expected to be completed in the fourth quarter of 2025.お知らせ • Nov 22Lifco AB (Publ) Announces That Axel Wachtmeister as Board Member Will Not Be Available for Re-Election in 2026Lifco AB (publ) informed that the current Board member Axel Wachtmeister, who has served since 2006, has announced that he will not be available for re-election in 2026.お知らせ • Nov 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hegutechnik GmbH & Co. Kg.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hegutechnik GmbH & Co. Kg. on November 3, 2025. HEGUtechnik will be consolidated in business area systems solutions, division Contract Manufacturing. The acquisition will not have any significant effect on Lifco's earnings or financial position in the current financial year. In 2024, HEGUtechnik reported net sales of approximately €10.3 million. Consolidation is expected to take place in the fourth quarter of 2025.Recent Insider Transactions • Oct 31Head of Business Area Systems Solutions recently bought €189k worth of stockOn the 24th of October, Martin Linder bought around 6k shares on-market at roughly €34.33 per share. This transaction amounted to 2.6% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €298k. Insiders have collectively bought €5.8m more in shares than they have sold in the last 12 months.お知らせ • Oct 24+ 3 more updatesLifco AB (publ) to Report Q1, 2026 Results on Apr 28, 2026Lifco AB (publ) announced that they will report Q1, 2026 results on Apr 28, 2026お知らせ • Sep 12Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Citodent Imaging B.V.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Citodent Imaging B.V. on September 11, 2025. Citodent Imaging will be consolidated in Business Area Dental. The acquisition will not have any significant effect on Lifco’s earnings or financial position in the current financial year. For the period ending December 31, 2024, Citodent Imaging B.V. reported total revenue of €1.2 million and has eight employees. Consolidation is expected to take place in the third quarter of 2025.お知らせ • Aug 02Lifco AB (publ) (OM:LIFCO B) agreed to acquire Maximover Limited.Lifco AB (publ) (OM:LIFCO B) agreed to acquire Maximover Limited on August 1, 2025. For the period ending May 31, 2025, Maximover Limited reported total revenue of £39 million. The transaction is expected to take place in the third quarter of 2025.お知らせ • Jul 27Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire unknown majority stake in Stoffl Rudolf GmbH.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire unknown majority stake in Stoffl Rudolf GmbH on July 25, 2025. In 2024, Stöffl reported net sales of approximately EUR 14.6 million. Consolidation is expected to take place in the third quarter of 2025.お知らせ • Jul 22Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ur Fog S.R.L.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ur Fog S.R.L. on July 22, 2025. For the period ending December 31, 2024, Ur Fog S.R.L. reported total revenue of €7.8 million. The expected completion of the transaction is in third quarter of 2025.お知らせ • Jul 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hedon Electronic Developments B.v.Lifco AB (publ) (OM:LIFCO B) agreed to acquire an unknown majority stake in Hedon Electronic Developments B.v. on July 3, 2025. For the period ending December 31, 2024, Hedon Electronic Developments B.v. reported total revenue of €7.4 million. HedoN will be consolidated in Business Area Systems Solutions, division Special Products. Consolidation is expected to take place in the third quarter of 2025.お知らせ • Jun 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Klemko Techniek B.V.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Klemko Techniek B.V. on June 4, 2025. Klemko Group will be consolidated in Business Area Systems Solutions, division Infrastructure Products. For the period ending December 31, 2024, Klemko Techniek B.V. reported total revenue of €19.1 million. The expected completion of the transaction is in second quarter of 2025..お知らせ • Apr 25Lifco AB (Publ) Approves DividendLifco AB (publ) at its Annual General Meeting held on 25 April 2025, In accordance with the proposal of the Board of Directors and the CEO, the Meeting resolved to declare a dividend of SEK 2.40 per share. 29 April 2025 was determined as record date for dividend.お知らせ • Apr 24Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Gestenco International Aktiebolag.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Gestenco International Aktiebolag on April 24, 2025. As part of the acquisition, Gestenco International will be consolidated in Business Area Dental. The consolidation is expected to take place in the second quarter of 2025. The acquisition will not have any significant effect on Lifco’s earnings or financial position in the current financial year. For the period ending December 31, 2024, Gestenco International Aktiebolag reported total revenue of SEK 19 million.お知らせ • Jan 31Lifco AB (publ), Annual General Meeting, Apr 25, 2025Lifco AB (publ), Annual General Meeting, Apr 25, 2025, at 11:00 W. Europe Standard Time. Location: bonnierhuset, torsgatan 21, stockholm Sweden株主還元1LIFCIT IndustrialsIT 市場7D3.5%-0.4%-1.2%1Y-18.2%19.5%26.0%株主還元を見る業界別リターン: 1LIFC過去 1 年間で19.5 % の収益を上げたItalian Industrials業界を下回りました。リターン対市場: 1LIFCは、過去 1 年間で26 % のリターンを上げたItalian市場を下回りました。価格変動Is 1LIFC's price volatile compared to industry and market?1LIFC volatility1LIFC Average Weekly Movement7.4%Industrials Industry Average Movement4.8%Market Average Movement4.8%10% most volatile stocks in IT Market8.4%10% least volatile stocks in IT Market3.0%安定した株価: 1LIFCの株価は、 Italian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 1LIFCの 週次ボラティリティ は過去 1 年間で17%から7%に減少しましたが、依然としてItalian株の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19467,912Per Waldemarsonwww.lifco.seLifco AB (publ)は、スウェーデン、ノルウェー、ドイツ、その他のヨーロッパ、英国、アジア、オーストラリア、イタリア、北米、および国際的な歯科、解体・工具、システムソリューション事業に従事している。義歯アタッチメント、消毒剤、唾液排出装置、咬合採得・印象材、ボンディング剤、その他消耗品などの歯科医療機器の販売、カルテシステムの開発・販売を行っている。また、歯科技工所の運営、技術サービスやソフトウェアサービスも提供している。また、重機械製造、インフラ、解体、建設、林業、原子力、セメント、プロセス業界向けに、解体ロボット、林業機械、クレーン・ショベル用アタッチメントなどの開発・製造・販売も行っている。さらに、電気設備や電力生産用の機械設備、電気機器、各種材料のリサイクル用機器、船舶や海洋設備用のコンプレッサー、サービスカー用の内装、車両輸送用のトレーラーなども提供している。さらに、電子部品、ステンレス鋼、亜鉛メッキ製品などの受託製造、環境技術、電化、LED照明、リフト安全、リライニング、雷保護、測定器、通信などのインフラ製品、コーヒーメーカー、漫画・スリービングソリューション、特殊機器、衣料品などの特殊製品、ターポリンシステム、高度なリフティングシステム、航空機地上サービス用機器、トラック用ライトバー、サービスバン用車両ラッキングシステムなどの輸送製品も提供している。同社は1946年に設立され、スウェーデンのエンショーピンに本拠を置く。Lifco AB（publ）はCarl Bennet ABの子会社。もっと見るLifco AB (publ) 基礎のまとめLifco の収益と売上を時価総額と比較するとどうか。1LIFC 基礎統計学時価総額€12.70b収益（TTM）€337.95m売上高(TTM)€2.60b37.6xPER（株価収益率4.9xP/Sレシオ1LIFC は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計1LIFC 損益計算書（TTM）収益SEK 28.50b売上原価SEK 15.99b売上総利益SEK 12.51bその他の費用SEK 8.81b収益SEK 3.70b直近の収益報告Mar 31, 2026次回決算日Jul 14, 2026一株当たり利益（EPS）8.14グロス・マージン43.90%純利益率12.97%有利子負債／自己資本比率22.8%1LIFC の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.9%現在の配当利回り33%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 10:45終値2026/06/17 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Lifco AB (publ) 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。10 アナリスト機関null nullABG Sundal CollierRobert RedinCarnegie Investment Bank ABJakob MarkenDanske Bank7 その他のアナリストを表示
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Anders Oscarsson was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 25Lifco AB (Publ) Appoints Anders Oscarsson as New Member of the BoardLifco AB (publ) at its AGM held on 24 April 2026 approved that Anders Oscarsson was elected new member of the Board.
お知らせ • Mar 17Lifco AB (publ) to Report Fiscal Year 2026 Final Results on Mar 30, 2027Lifco AB (publ) announced that they will report fiscal year 2026 final results on Mar 30, 2027
お知らせ • Mar 11Lifco AB (publ) to Report Fiscal Year 2025 Final Results on Mar 30, 2026Lifco AB (publ) announced that they will report fiscal year 2025 final results on Mar 30, 2026
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €27.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 14x in the Industrials industry in Europe. Total loss to shareholders of 20% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €26.67 per share.
お知らせ • Jan 31+ 1 more updateLifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd on January 30, 2026. As part of the transaction, Ethoss will be consolidated in Business Area Dental. For the period ending July 31, 2025, Ethoss Regeneration Ltd reported total revenue of approximately £5.4 million. The expected completion of the transaction is in the first quarter of 2026.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Anders Oscarsson was the last independent director to join the board, commencing their role in 2026. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 25Lifco AB (Publ) Appoints Anders Oscarsson as New Member of the BoardLifco AB (publ) at its AGM held on 24 April 2026 approved that Anders Oscarsson was elected new member of the Board.
お知らせ • Mar 17Lifco AB (publ) to Report Fiscal Year 2026 Final Results on Mar 30, 2027Lifco AB (publ) announced that they will report fiscal year 2026 final results on Mar 30, 2027
お知らせ • Mar 11Lifco AB (publ) to Report Fiscal Year 2025 Final Results on Mar 30, 2026Lifco AB (publ) announced that they will report fiscal year 2025 final results on Mar 30, 2026
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €27.10, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 14x in the Industrials industry in Europe. Total loss to shareholders of 20% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €26.67 per share.
お知らせ • Jan 31+ 1 more updateLifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ethoss Regeneration Ltd on January 30, 2026. As part of the transaction, Ethoss will be consolidated in Business Area Dental. For the period ending July 31, 2025, Ethoss Regeneration Ltd reported total revenue of approximately £5.4 million. The expected completion of the transaction is in the first quarter of 2026.
お知らせ • Jan 30Lifco AB (publ) Proposes Dividend for the Year 2025, Payable on 6 May 2026The Board of Directors of Lifco AB (publ) and Chief Executive Officer proposed that the Annual General Meeting authorise the payment of a dividend of SEK 2.70 per share (SEK 2.40 per share) for 2025, representing a total distribution of SEK 1,226.4 million (SEK 1,090.1 million). This is equal to 33.8% (33.0%) of the net profit for the year attributable to shareholders of Lifco AB. The proposed record date for the dividend is 30 April 2026. Euroclear Sweden expects to be able to distribute the dividend to the shareholders on 6 May 2026, subject to the resolution of the Annual General Meeting.
お知らせ • Nov 26Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Db Orthodontics Limited.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Db Orthodontics Limited on November 25, 2025. DB Orthodontics Limited will be consolidated in Business Area Dental. In the financial year ended October 2025, DB Orthodontics Limited reported net sales of approximately £8.9 million. The transaction is expected to be completed in the fourth quarter of 2025.
お知らせ • Nov 22Lifco AB (Publ) Announces That Axel Wachtmeister as Board Member Will Not Be Available for Re-Election in 2026Lifco AB (publ) informed that the current Board member Axel Wachtmeister, who has served since 2006, has announced that he will not be available for re-election in 2026.
お知らせ • Nov 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hegutechnik GmbH & Co. Kg.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hegutechnik GmbH & Co. Kg. on November 3, 2025. HEGUtechnik will be consolidated in business area systems solutions, division Contract Manufacturing. The acquisition will not have any significant effect on Lifco's earnings or financial position in the current financial year. In 2024, HEGUtechnik reported net sales of approximately €10.3 million. Consolidation is expected to take place in the fourth quarter of 2025.
Recent Insider Transactions • Oct 31Head of Business Area Systems Solutions recently bought €189k worth of stockOn the 24th of October, Martin Linder bought around 6k shares on-market at roughly €34.33 per share. This transaction amounted to 2.6% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth €298k. Insiders have collectively bought €5.8m more in shares than they have sold in the last 12 months.
お知らせ • Oct 24+ 3 more updatesLifco AB (publ) to Report Q1, 2026 Results on Apr 28, 2026Lifco AB (publ) announced that they will report Q1, 2026 results on Apr 28, 2026
お知らせ • Sep 12Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Citodent Imaging B.V.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Citodent Imaging B.V. on September 11, 2025. Citodent Imaging will be consolidated in Business Area Dental. The acquisition will not have any significant effect on Lifco’s earnings or financial position in the current financial year. For the period ending December 31, 2024, Citodent Imaging B.V. reported total revenue of €1.2 million and has eight employees. Consolidation is expected to take place in the third quarter of 2025.
お知らせ • Aug 02Lifco AB (publ) (OM:LIFCO B) agreed to acquire Maximover Limited.Lifco AB (publ) (OM:LIFCO B) agreed to acquire Maximover Limited on August 1, 2025. For the period ending May 31, 2025, Maximover Limited reported total revenue of £39 million. The transaction is expected to take place in the third quarter of 2025.
お知らせ • Jul 27Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire unknown majority stake in Stoffl Rudolf GmbH.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire unknown majority stake in Stoffl Rudolf GmbH on July 25, 2025. In 2024, Stöffl reported net sales of approximately EUR 14.6 million. Consolidation is expected to take place in the third quarter of 2025.
お知らせ • Jul 22Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ur Fog S.R.L.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Ur Fog S.R.L. on July 22, 2025. For the period ending December 31, 2024, Ur Fog S.R.L. reported total revenue of €7.8 million. The expected completion of the transaction is in third quarter of 2025.
お知らせ • Jul 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Hedon Electronic Developments B.v.Lifco AB (publ) (OM:LIFCO B) agreed to acquire an unknown majority stake in Hedon Electronic Developments B.v. on July 3, 2025. For the period ending December 31, 2024, Hedon Electronic Developments B.v. reported total revenue of €7.4 million. HedoN will be consolidated in Business Area Systems Solutions, division Special Products. Consolidation is expected to take place in the third quarter of 2025.
お知らせ • Jun 04Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Klemko Techniek B.V.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire an unknown majority stake in Klemko Techniek B.V. on June 4, 2025. Klemko Group will be consolidated in Business Area Systems Solutions, division Infrastructure Products. For the period ending December 31, 2024, Klemko Techniek B.V. reported total revenue of €19.1 million. The expected completion of the transaction is in second quarter of 2025..
お知らせ • Apr 25Lifco AB (Publ) Approves DividendLifco AB (publ) at its Annual General Meeting held on 25 April 2025, In accordance with the proposal of the Board of Directors and the CEO, the Meeting resolved to declare a dividend of SEK 2.40 per share. 29 April 2025 was determined as record date for dividend.
お知らせ • Apr 24Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Gestenco International Aktiebolag.Lifco AB (publ) (OM:LIFCO B) signed an agreement to acquire Gestenco International Aktiebolag on April 24, 2025. As part of the acquisition, Gestenco International will be consolidated in Business Area Dental. The consolidation is expected to take place in the second quarter of 2025. The acquisition will not have any significant effect on Lifco’s earnings or financial position in the current financial year. For the period ending December 31, 2024, Gestenco International Aktiebolag reported total revenue of SEK 19 million.
お知らせ • Jan 31Lifco AB (publ), Annual General Meeting, Apr 25, 2025Lifco AB (publ), Annual General Meeting, Apr 25, 2025, at 11:00 W. Europe Standard Time. Location: bonnierhuset, torsgatan 21, stockholm Sweden
